Cargando…
Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients
This cohort study compares the antispike antibody titers of the mRNA-1273 and BNT162b2 vaccines for SARS-CoV-2 in incrementally immunosuppressed patients.
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Medical Association
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112067/ https://www.ncbi.nlm.nih.gov/pubmed/35576009 http://dx.doi.org/10.1001/jamanetworkopen.2022.11897 |
| _version_ | 1784709348571742208 |
|---|---|
| author | Mitchell, Jonathan Connolly, Caoilfhionn M. Chiang, Teresa Po-Yu Alejo, Jennifer L. Werbel, William A. Segev, Dorry L. Massie, Allan B. |
| author_facet | Mitchell, Jonathan Connolly, Caoilfhionn M. Chiang, Teresa Po-Yu Alejo, Jennifer L. Werbel, William A. Segev, Dorry L. Massie, Allan B. |
| author_sort | Mitchell, Jonathan |
| collection | PubMed |
| description | This cohort study compares the antispike antibody titers of the mRNA-1273 and BNT162b2 vaccines for SARS-CoV-2 in incrementally immunosuppressed patients. |
| format | Online Article Text |
| id | pubmed-9112067 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Medical Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91120672022-06-04 Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients Mitchell, Jonathan Connolly, Caoilfhionn M. Chiang, Teresa Po-Yu Alejo, Jennifer L. Werbel, William A. Segev, Dorry L. Massie, Allan B. JAMA Netw Open Research Letter This cohort study compares the antispike antibody titers of the mRNA-1273 and BNT162b2 vaccines for SARS-CoV-2 in incrementally immunosuppressed patients. American Medical Association 2022-05-16 /pmc/articles/PMC9112067/ /pubmed/35576009 http://dx.doi.org/10.1001/jamanetworkopen.2022.11897 Text en Copyright 2022 Mitchell J et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License. |
| spellingShingle | Research Letter Mitchell, Jonathan Connolly, Caoilfhionn M. Chiang, Teresa Po-Yu Alejo, Jennifer L. Werbel, William A. Segev, Dorry L. Massie, Allan B. Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients |
| title | Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients |
| title_full | Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients |
| title_fullStr | Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients |
| title_full_unstemmed | Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients |
| title_short | Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients |
| title_sort | comparison of sars-cov-2 antibody response after 2-dose mrna-1273 vs bnt162b2 vaccines in incrementally immunosuppressed patients |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112067/ https://www.ncbi.nlm.nih.gov/pubmed/35576009 http://dx.doi.org/10.1001/jamanetworkopen.2022.11897 |
| work_keys_str_mv | AT mitchelljonathan comparisonofsarscov2antibodyresponseafter2dosemrna1273vsbnt162b2vaccinesinincrementallyimmunosuppressedpatients AT connollycaoilfhionnm comparisonofsarscov2antibodyresponseafter2dosemrna1273vsbnt162b2vaccinesinincrementallyimmunosuppressedpatients AT chiangteresapoyu comparisonofsarscov2antibodyresponseafter2dosemrna1273vsbnt162b2vaccinesinincrementallyimmunosuppressedpatients AT alejojenniferl comparisonofsarscov2antibodyresponseafter2dosemrna1273vsbnt162b2vaccinesinincrementallyimmunosuppressedpatients AT werbelwilliama comparisonofsarscov2antibodyresponseafter2dosemrna1273vsbnt162b2vaccinesinincrementallyimmunosuppressedpatients AT segevdorryl comparisonofsarscov2antibodyresponseafter2dosemrna1273vsbnt162b2vaccinesinincrementallyimmunosuppressedpatients AT massieallanb comparisonofsarscov2antibodyresponseafter2dosemrna1273vsbnt162b2vaccinesinincrementallyimmunosuppressedpatients |